Breast tumor stroma: A driving force in the development of resistance to therapies
M Majidinia, B Yousefi - Chemical biology & drug design, 2017 - Wiley Online Library
Breast cancer is the most common cancer and the second leading cause of cancer‐related
death in women worldwide. In spite of huge advancements in early detection and ever …
death in women worldwide. In spite of huge advancements in early detection and ever …
Peroxisome proliferator-activated receptors and their ligands in cancer drug-resistance: opportunity or challenge
B Yousefi, N Zarghami, N Samadi… - Anti-cancer agents in …, 2016 - ingentaconnect.com
Development of resistance in cancer cells results in a high failure rate in cancer
chemotherapy in the clinic. Therefore, investigating the mechanisms by which cancer cells …
chemotherapy in the clinic. Therefore, investigating the mechanisms by which cancer cells …
Genetic variation of ABCB1 (rs1128503, rs1045642) and CYP2E1 rs3813867 with the duration of tuberculosis therapy: a pilot study among tuberculosis patients in …
Objective The risk of contracting tuberculosis (TB) and the efficacy of TB therapy are affected
by several factors, including genetic variation among populations. In the Indonesian …
by several factors, including genetic variation among populations. In the Indonesian …
[PDF][PDF] The effects of diet and geographic ancestry on drug-metabolising enzyme activity in Europeans and South Asians
SK Eagles - 2018 - core.ac.uk
This thesis is the result of original investigations carried out by Shane K. Eagles within the
Faculty of Pharmacy, at the University of Sydney, under the supervision of Professor Andrew …
Faculty of Pharmacy, at the University of Sydney, under the supervision of Professor Andrew …